Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment - Cardiovascular News

Summary by Cardiovascular News
Reprieve Cardiovascular has announced the first-in-human results of the Reprieve System at the CSI Focus D-HF—device therapies in heart failure—conference (13–14 December, Frankfurt, Germany). Results of the study demonstrated the potential of the Reprieve system to safely accelerate and maximise decongestion while reducing the likelihood of kidney injury for patients with ADHF. “Heart failure patients with fluid volume overload are particularly…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)